Sara L.Rafferty

Sara Rafferty represents commercial clients in complex civil litigation matters as well as in administrative and regulatory challenges involving the government. She has defended clients against federal and state governments in False Claims Act (FCA) lawsuits, Foreign Corrupt Practices Act (FCPA) investigations, Congressional investigations, and sanctions investigations and disclosures before the Office of Foreign Assets Control (OFAC).

Sara's litigation practice involves overseeing complex case discovery, developing case strategy, researching legal issues, and drafting motions and briefs. Her practice focuses on representing clients in the health care, hospital systems, laboratory, pharmaceutical, and life sciences industries in litigation and investigations. Sara's practice includes qui tam actions, government and internal investigations, and payor-provider disputes. She has also defended corporate clients against claims brought under the Employee Retirement Income Security Act (ERISA) through a series of withdrawal liability arbitrations.

In addition to investigations and litigation, Sara represents clients in challenging rulemakings before regulatory authorities. She has advised and crafted oral testimony and written submissions before the U.S. Trade Representative's Section 301 Committee and the Federal Communications Commission.

Prior to joining Jones Day, Sara served for four years as a staff member in the U.S. House of Representatives, where she was a policy advisor on numerous issues. After leaving government service, she spent three years lobbying on behalf of corporations on health care and national security issues while pursuing a law degree at Georgetown University. She is actively involved in the Dallas arts community and graduated from the Dallas Business Council of the Arts Leadership Arts Institute.